Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$33K Buy
+460
New +$32K ﹤0.01% 777
2021
Q3
Sell
-73
Closed -$5K 987
2021
Q2
$5K Hold
73
﹤0.01% 757
2021
Q1
$5K Hold
73
﹤0.01% 786
2020
Q4
$5K Buy
+73
New +$5.15K ﹤0.01% 789
2016
Q1
Sell
-100
Closed -$4K 722
2015
Q4
$4K Buy
+100
New +$3.89K ﹤0.01% 674

Other funds holding HOLX

Bartlett & Co's HOLX Position: Q4 2023 in Review

Bartlett & Co opened a new position in Hologic (HOLX) in Q4 2023: 460 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: Bartlett & Co previously reported a position in HOLX as recently as Q2 2021.

Bartlett & Co first reported a position in HOLX in Q4 2015 and has held it in 5 quarters since. 732 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Bartlett & Co held 460 shares of Hologic worth $33K as of Q4 2023.
  • Hologic was a new Bartlett & Co position in Q4 2023.
  • Hologic made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #777 holding.
  • Bartlett & Co first reported a position in Hologic in Q4 2015 and has held it in 5 quarters since.
  • 732 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.